Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
EV/Core EBITDA

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 34.08--0.060.100.23

What is the latest EV/Core EBITDA ratio of CONCORD BIOTECH ?

The latest EV/Core EBITDA ratio of CONCORD BIOTECH is 34.08 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202434.08
Mar2023-
Mar2022-0.06
Mar20210.10
Mar20200.23

How is EV/Core EBITDA of CONCORD BIOTECH Trending?

Years EV/Core EBITDA % Change
Mar2024 34.08
0
Mar2023 0
100.00
Mar2022 -0.06
Negative
Mar2021 0.1
-56.52
Mar2020 0.23 -

Other Financial Ratios of CONCORD BIOTECH


Compare EV/Core EBITDA ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹18,196.2 Cr -5.9% -5.9% 13.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,284.0 Cr -0% -0.4% 10.2% Stock Analytics
DIVIS LABORATORIES ₹183,268.0 Cr 1.4% 4.1% 50.3% Stock Analytics
CIPLA ₹122,253.0 Cr 0.5% 1.6% 1.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹113,988.0 Cr -1.2% 7.1% 18.3% Stock Analytics
DR REDDYS LABORATORIES ₹108,921.0 Cr 1.7% 1.2% 1.5% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-5.9%

-5.9%

13.6%

SENSEX

-0.7%

3%

5%


You may also like the below Video Courses